Mitochondrion, a key subcellular organelle, acts as the cell's energy supplier and metabolic regulator. Given its vital functions and distinct thermal sensitivity, it's a suitable target for tumor photothermal therapy (PTT). However, current mitochondrial targeting agents are easily cleared during in vivo circulation and may non-specifically target normal cells. Herein, to address these issues, a novel cascade-targeting molecularly imprinted polymer (MIP) with charge-reversal capability was constructed, avoiding exogenous ligand modification. During MIP synthesis, Fe3O4 modified with (3-carboxypropyl)triphenylphosphonium bromide was used as the carrier to provide photothermal effect and mitochondrial targeting. Furthermore, incorporating 2-methacryloyloxyethyl phosphorylcholine boosted the imprinting factor and endowed charge reversal, enabling specific, stealthy tumor targeting and enhanced cellular internalization under weak acidity. Following intracellular entry, glutathione-mediated degradation of the reductive cross-linker released the carrier for second-stage mitochondrial targeting. Thereafter, under 808 nm laser irradiation, Fe3O4 exerted a robust photothermal effect. Cellular uptake and mitochondrial colocalization confirmed cascade targeting capability, while in vitro tumor spheroid penetration demonstrated charge-reversal MIP facilitated more efficient internalization. In vivo experiments revealed MIP exhibited the strongest anti-tumor efficacy under irradiation. This work fully leveraged the designability of MIP, integrating charge reversal with cascade targeting functionalities, and provided a novel strategy for improving PTT.
Building similarity graph...
Analyzing shared references across papers
Loading...
Fang Wang
Yao‐Jia Ma
Dawei Wang
Advanced Healthcare Materials
Nankai University
Dalian Institute of Chemical Physics
Building similarity graph...
Analyzing shared references across papers
Loading...
Wang et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69ba421b4e9516ffd37a20c6 — DOI: https://doi.org/10.1002/adhm.202505935